During recent years, DNA microarrays have become the method of choice to monitor the expression level of a large number of genes. Depending on the focus of the study and the method of microarray fabrication, a number of different strategies for probe selection may be most appropriate. One consideration concerns the length of the probe, ranging from some 25 residues used for oligonucleotide arrays to complete cDNAs. Unless resources are truly unlimited, an important decision to be made is the amount of effort to be put into the selection of genes and gene fragments. While high-throughput cDNA arraying projects usually will select from a collection of existing cDNA clones, smaller projects focusing on a number of selected genes can afford to selectively amplify fragments optimised for that purpose. This paper discusses the full scope of probe selection strategies, highlighting the problems that may be encountered in the various systems.
GENERAL CONSIDERATIONS
DNA microarrays are made up of a collection of distinct nucleic acid samples, arranged in a regular lattice of spots on a solid support generally made of coated glass. Arrays intended to monitor changes in the expression level of various genes use cDNA samples or synthetic oligonucleotides derived from cDNA sequences. 1, 2 Other possible array applications include the detection of mutations or copy number changes on the genome level 3±5 and thus use samples derived from genomic DNA. The successful application of each DNA microarray technique requires particular conditions and prerequisites, which impose certain criteria for selecting appropriate DNA probes. The following paragraphs focus on probe selection strategies for the more widely used expression arrays of both the oligonucleotide-and cDNA-using variety. Nevertheless, some of these criteria are also valid for mutation-detection arrays.
When monitoring the expression level of a large number of genes, suf®cient sensitivity and speci®city of an array, as well as the broad coverage of all relevant genes, are of crucial importance. In addition, the quality of the array should guarantee the reproducibility of the results to ensure their statistical signi®cance. A further prerequisite for a successful interpretation of the array results is a correct assignment and annotation of the DNA probes, providing an unambiguous link to the corresponding entries in gene and literature databases.
Some aspects of probe design, including the fragment length, are in¯uenced by the manufacturing process of the arrays. Photolithographic procedures allow a massively parallel production of oligonucleotide arrays, but are restricted to an oligonucleotide length of 20±25 nucleotides due to the high error rate of each extension cycle.
6±8
Alternative methods for in situ oligonucleotide synthesis, employing high-precision delivery of chemical reagents by using micro¯uidic channels or inkjet pumps, 9±11 allow more variable oligonucleotide lengths. A further possibility is the direct spotting of externally generated oligonucleotide-or cDNA-probes onto the array surface, using either pin-or inkjet-based procedures. 12±14 Besides removing all probe-length limitations, the latter approaches offer the advantage that probes can be quality-controlled before the spotting process. Whenever singlestranded DNA (ssDNA) or oligonucleotides are used as array probes, their orientation relative to the gene must be known. The importance of this issue became apparent recently, when wrongly annotated entries from primary databases had caused the usage of wrongly oriented oligonucleotides on a commercially available DNA microarray. 15, 16 Several distinct properties of the probes in¯uence the hybridisation kinetics and the sensitivity of a microarray. 17, 18 When using oligonucleotides as probes, the probe length and the melting point T m of the expected duplex are of crucial importance. 9, 19 Further attention has to be paid to other sequence characteristics such as, for example, the composition and order of bases. 20, 21 Computer programs designed for the optimal choice of oligonucleotide sequences are available.
22±24 Short oligonucleotides are suitable for distinguishing between perfectly matched duplexes and singlebase or two-base mismatches. 14, 25, 26 Spacer molecules, which increase the distance of the hybridising portion of the probe to the array surface, are required to improve the otherwise unfavourable hybridisation properties of oligonucleotide arrays as compared to cDNA arrays. 27±29 Both length and charge of the spacer are critical for the hybridisation ef®ciency. 27 When working with short oligonucleotide probes, the use of several different oligonucleotides corresponding to a single gene is typically required to enhance the reliability of the hybridisation signals. 28 Longer DNA fragments have more reliable hybridisation properties but the increased viscosity might complicate the array manufacturing process. In addition, increasing the fragment length raises the danger of non-speci®c cross-hybridisation events. If fragments of very heterogeneous length are used, the comparability of the investigated genes and the robustness of the array might suffer from the different hybridisation kinetics. Oligonucleotide probes with the length of 50±60 nucleotides may not be suitable for reliably distinguishing single base mismatches, but show an improved speci®city and sensitivity compared to shorter oligonucleotides.
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STRATEGIES
The most appropriate probe selection strategy depends primarily on the objective of the experiment. As summarised in Figure 1 , there is a whole spectrum of different approaches, differing in aspects of throughput, accuracy and the necessary effort before and after the microarray experiment.
In situations where little prior information on relevant genes is available, or where the prime motivation is an unbiased overview of global changes in gene expression patterns, the high-density method is the appropriate choice. Typically, samples are selected from a preexisting collection of cDNA sequences or fragments, or they are synthesised by a method amenable to high throughput. The downside of this approach is a general lack of reliable sample annotation, shifting some of the necessary work to the post-hybridisation phase. These highdensity microarrays, which aim to cover the complete transcriptome of a biological system, 2, 7 are in contrast to small but specialised arrays that are designed with a focus on de®ned subject areas such as, for example, genes relevant to a particular metabolic pathways or a particular tissue type. 31, 32 The limited number of DNA fragments on these low-density arrays allows a more thorough selection and annotation protocol. Obviously, there also exists a whole range of intermediates Physical properties of the probe in¯uence hybridisation kinetics High coverage but poor sample annotation in high density arrays Short vs. long array probes between ultrahigh-density and highaccuracy arrays. In the following paragraphs, some common strategies for probe selection are discussed.
The easiest and cheapest method consists of the spotting of clones from a library without prior sequencing. Only those clones that show differential expression after hybridisation are submitted to sequencing and further analysis. This strategy is particularly useful for arrays produced in small editions, since only a small fraction of presumably interesting genes must be annotated. The more frequently a particular array set-up is used, the less ef®cient becomes the deferment of the sequence analysis. Typical applications include highthroughput screens for potential new drug targets, 33, 34 or the analysis of`exotic' biological systems without any available sequence information. Owing to the frequent representation bias of some genes, a normalisation of the library used is strongly recommended for reaching a more equal distribution. 35 A somewhat more re®ned strategy relies on available collections of sequenced cDNA clones. Most of the available clones have the status of ESTs (expressed sequence tags 36 ), and their corresponding sequences are collected in the dbEST database. 37 Access to the physical clones of most animal ESTs is provided by the IMAGE consortium (Integrated Molecular Analysis of Genomes and their Expression), 38 and by several distributors. Since clones from this exhaustive collection are also available in large sets, they are a valuable and widely used source for microarray probes. For plants and other organisms, similar sources exist.
A common problem when dealing with EST clones is their sometimes poor reliability. Halgren et al. analysed 1,189 cDNA sequences of clones ordered from such a collection, and found that only 62 per cent of the stocks represented a pure sample of the correct clone. 39 Even cleaned up,`sequence-veri®ed' cDNA clone sets can contain high error rates of up to 30 per cent. 15 Three different types of mistakes have been observed: (1) the sequence in the database is different from the one found in the obtained cDNA clone; (2) the sequence is correct, but the corresponding gene annotation is wrong; and (3) the predicted orientation is wrong.
When using EST clones as array probes, an obvious problem is redundancy. Most genes are represented by multiple EST clones ± for highly expressed genes, the EST counts can range to 1,000 and more. A widely used method for controlling redundancy is the clustering of EST data. 40, 41 This process is of great importance for the generation of microarrays; the advantages and several pitfalls are discussed in the next section.
Whenever prior information on relevant genes or gene families is available, a preselection can be carried out by ®rst assembling a list of genes of interest ®rst, and then selecting EST clones on the basis of this list. The cDNA contained in these EST clones can either be used directly for the production of microarrays, or serve as template for the generation of genespeci®c oligonucleotides.
The most reliable, but also most costly and time-consuming probe selection strategy is the ampli®cation of suitable sequence regions from pre-selected genes by polymerase chain reaction (PCR; see section`Fragment selection' for details). By doing so, manufacturers of microarrays can adjust important properties of the The quality of ESTbased arrays depends on the reliability of the library used Spotting without prior sequencing PCR-ampli®cation is the most reliable but most expensive probe generating method Figure 1 : Selection strategies ranging from high accuracy to high throughput DNA fragments such as length, orientation or position within the mRNA to the individual experimental approach. While at least some aspects of this strategy can be partially automated, the large amount of manufacturing effort needed makes this approach more suited for the generation of low-and medium-density microarrays, developed to address de®ned biological or medical questions, and produced in larger editions.
CLUSTERING
A marked disadvantage of spotting large numbers of apparently non-identical EST clones or similarly uncharacterised cDNAs is the inherent redundancy. Depending on the complexity of the cDNA library used, a certain number of selected clones might correspond to a single gene and thus contribute nothing to the coverage of the array. In extreme cases such as erythrocyte-derived cDNAs, the majority of selected clones will represent exclusively á-and â-globin, unless an effective library normalisation has been performed. Redundancy, when recognised as such, can also have the desirable effect of providing additional support for observed expression differences. Nevertheless, excessive redundancy has to be avoided whenever coverage or ef®ciency is an issue.
The method of choice for controlling redundancy in microarray probe selection is the use of clustered data. 40, 41 In the clustering process, cDNA clones belonging to a single gene are recognised by their overlapping sequences. Even sequence pairs that do not overlap can be assigned to the same cluster ± and hence the same gene ± whenever`bridging' sequences are found that overlap with both of them. A distinction should be made between sequence clustering and sequence assembly: the former method groups overlapping sequence sets without inferring any particular order within each cluster. By contrast, sequence assembly uses clustered sequences and combines them to a`consensus' sequence, which ideally encompasses all sequence fragments of that particular cluster.
For most of the public large-scale EST sequencing projects, there are also publicly available EST cluster databases. Most notable in this respect is the NCBImaintained Unigene database, which provides clustered (but not assembled) datasets for all EST and Genbank sequences of human, murine, rat, bovine, Xenopus and zebra®sh origin. 42 The Unigene clusters are the basis for several sets of cDNA array probes. Conceptually similar datasets for clustered EST sequences are provided by TIGR 43 and SANBI. 41 Software packages for sequence clustering are also available, allowing the clustering of sequence collections not addressed by the projects mentioned above, including proprietary data. The clustering of EST data offers a number of pitfalls, some of which are very hard to avoid, even when all necessary care is taken. The ®rst problem becomes obvious when comparing the number of human Unigene clusters with the gene count estimates obtained from the human genome. The much larger number of clusters is probably the result of underclustering', ie the failure to combine all EST/cDNA sequences corresponding to a single gene. Frequently, two clusters per gene are observed, one being formed by 59-EST sequences, the other one consisting of 39-ESTs. For genes encoding large cDNAs, the number of clusters per gene can even be greater than two. While this underclustering' problem is frequent and hard to avoid, its consequences are typically not severe. In the worst case, multiple probes per gene are selected, yielding a certain unwanted redundancy.
Much more problematic is the opposite type of clustering error, the artefactual overclustering'. Here, sequences that do not correspond to the same gene are found erroneously combined within a single cluster. The major cause for this type of error is the presence of chimeric cDNA clones, containing sequence coming from more than one gene.
Uncharacterised
A related problem is the existence of repetitive elements in cDNA sequences, which occasionally can be so similar that an unwary program might count them as a true overlap. In almost all cases, an appropriate parametrisation of the clustering program should be able to overcome this error. A virtually unavoidable problem, by contrast, is the existence of physiologically overlapping transcribed regions in the genome. A good example is the mRNA for the thyroid hormone receptor NR1A1, which overlaps with the related NR1D1 mRNA by 300 bases at their respective 39 ends, in a tail-to-tail arrangement. Every conceivable automatic clustering program will inevitably group ESTs coming from both genes into a single cluster. There are multiple dangers for array probe selection in an unnoticed overclustering' situation. First, only a single probe is selected for two or more genes. Moreover, depending on the fragment selection, the probe might represent either gene or a combination of both. It is also possible that, as in the example mentioned above, the orientation of the cDNA changes at the chimeric boundary. Finally, the annotation of the cluster will be erratic unless a very good annotation system is used.
Despite the problems mentioned above, sequence clustering is a most useful method to avoid redundancy in microarray probe selection. When combined with a subsequent sequence assembly, the clustering process is also able to group protein-coding regions of a gene (which are required for proper annotation of the array probe) with the corresponding 39-untranslated regions. If the array method of choice requires knowledge of the mRNA orientation, it is advisable to extract this information from the open reading frame of the encoded protein, rather than to rely on the orientation information provided with unidirectionally cloned ESTs.
FRAGMENT SELECTION
After coming to a decision about the source of sequence information, one has to determine whether the complete cDNA/EST clone is to be spotted onto the array, or whether a pre-selected part of the sequence or even one or more oligonucleotides should be used. The use of complete cDNA sequences bears the danger of cross-hybridisation, either caused by closely related isoforms or by repetitive elements included in the cDNA.
A reliable prediction of the degree of sequence homology required for cross-hybridisation to occur is hardly possible. Hughes et al. showed that an average of 18 randomly placed mismatches within a oligonucleotide of 60 bp (corresponding to 70 per cent homology) are enough to reduce hybridisation to background level. 9 A similar threshold value of about 75 per cent was reported by Kane et al. after analysing microarrays consisting of 50mer oligonucleotides. 30 In addition to the absolute number of mismatched bases, the position of the mismatch relative to the array surface plays an important role. Thus, a single mismatch 10 bases from the 59end (which is 50 bases from the surface Unspeci®c hybridisation might be caused by closely related isoforms or repetitive elements attachment) has the same effect (,50 per cent signal reduction) as ®ve mismatches randomly distributed over the whole sequence. 9 Unspeci®c hybridisation signals can also be caused by repetitive elements such as Alu-repeats, microsatellite repeats, SINEs or LINEs (short or long interspersed elements) within the cDNA sequence. A comparison of the selected sequence with databases like REPBASE 44 will allow to identify and to avoid sequence regions prone to this complication.
An additional issue important for fragment selection is the potential existence of different mRNA species, all derived from a single gene of interest. Depending on the questions asked by the microarray experiment, a suitable array fragment should either detect all observed splice variants of a given gene, or only one speci®c variant. Most importantly, the expected hybridisation properties of the fragment should be documented. There are several physiological situations that cause the generation of different mRNA variants derived from a single gene; some of them are discussed below (Figure 2 ).
Alternative polyadenylation (Figure 2B)
Occasionally the untranslated 39 end of a gene is varied by the usage of alternative polyadenylation signals (for examples see Lin et al. 45 and Montoliu et al. 46 ). One has to distinguish between constitutive and regulated heterogeneity of the 39 end of a mRNA. In the ®rst case the selection of a 39 fragment would lower the sensitivity without in¯uencing the measured expression ratio. However, in the second case the selection of the fragment has an in¯uence on the expression ratio obtained. One possible strategy is the generation of multiple fragments, allowing the detection of regulated alternative polyadenylation. Another possibility is the selection of a single fragment with the aim of detecting all different splice variants of a mRNA. There are several approaches to the prediction of cryptic polyA signals, which facilitate the selection of appropriate Alternative splicing ( Figure 2C) Frequently, genes contain exons that are excised from the gene-derived premRNA in a constitutive or regulated manner (for examples see Groenen et al. 47 ). The consequences of this so-called alternative splicing' for the selection of a suitable array fragment are similar to the case of alternative polyadenylation. The localisation of the selected array fragment in a constitutively spliced region of the mRNA will exert a marked in¯uence on the sensitivity of the array. On the other hand, if the array fragment corresponds to an exon undergoing regulated splicing, only the generation of multiple fragments ensures that all splice variants of a mRNA are speci®cally detectable. If only the general expression level of the selected mRNA is of interest, a single array fragment, placed in a constitutively present region of the cDNA, should allow the detection of all known splice variants. The prediction of alternative splice events, purely based on the complete cDNA sequence, is not practicable. Experimental data such as, for example, alternatively spliced EST clones are required. Shoemaker et al. have developed a microarray-based procedure for the genome-wide prediction of mRNA splice variants and their tissuespeci®c expression. 48 The data generated by this method could develop into a generally applicable tool for array probe design applications in the future.
Alternative promoter usage ( Figure 2D) Similar to the 39 variability of a mRNA discussed above, its 59 end can differ through the mechanism of alternative promoter usage. 49 Since the promoter is the driving force for a gene's expression level, information on the speci®c usage of these alternative promoters is generally desirable. In this case, multiple fragments located close to their respective promoters are required. If the total RNA level is the sole focus of interest, a single downstream array fragment can be used. A bioinformatical prediction of alternatively used promoters is impractical at the moment. Thus, the tedious analysis of EST clones and literature data is also required in this case.
Taking all aforementioned factors into account, the advantages and disadvantages of certain fragment positions relative to the mRNA/cDNA-sequence can be summarised as follows (Figure 2A ). The choice of a fragment from the 39 untranslated region of a gene reduces the probability of cross-hybridisations with closely related isoforms. Additionally, this region is rarely affected by alternative splicing events. However, the potential existence of alternative polyadenylation signals and the elevated propensity for repetitive elements require a careful examination of the fragments concerning these trouble makers. A reliable annotation often turns out to be dif®cult, especially when based on long and potentially faulty chains of EST sequences linking the 39 end to the coding region. Microarray probes localised in the 59 untranslated regions are closely linked to the promoter. However, these regions are frequently missing in cDNA fragments generated by reverse transcription. Moreover, 59-untranslated regions are subject to the dangers of alternative promoter usage. Placing a probe into the coding region, ie the region of a mRNA/ cDNA that is translated into the corresponding protein sequence, enables the most reliable annotation. As an additional advantage, coding regions are devoid of repetitive elements. However, it is the coding region that shows the highest degree of conservation within a family of related sequences and therefore is most susceptible to cross-hybridisation events. This problem, together with the increased risk of alternative splicing, has to be thoroughly investigated before using coding region probes. If the 39-untranslated region of a gene is extremely long, it is possible that the coding region is not even reached in a reverse transcription.
A recommended multi-step strategy for the generation of a microarray probe would include the following steps ( Figure  3 ): After getting the complete sequence of the gene of interest, one should ®rst verify the sequence architecture, e.g. by crossspecies comparison. The second step includes the masking of repetitive elements as well as vector sequences and the region beyond the ®rst possible polyadenylation signal. After analysis of putative alternative splice events and the removal of ambiguous regions, the remaining sequence is used for similarity searches. Finally, a fragment is selected from the part of the sequence that has no apparent risk for cross-hybridisation with other closely related genes. This fragment should be suitable as a starting point for PCR-directed ampli®cation, but also could serve as a guide to select an appropriate EST clone. If ESTs are the source of sequence material, it is highly recommended that sequence-veri®ed clones are used.
GENE SELECTION
Besides the criteria for the selection of DNA fragments, another important question to address is how many genes, and which ones, should be spotted onto the array. A straightforward approach would be a collection that contains wellcharacterised DNA fragments corresponding to all genes of a given species. This goal has already been reached for some simple organisms such as the yeast Saccharomyces cerevisiae.
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Considering that, after the publication of a draft sequence of the human genome, the number of human genes is estimated to be 30±40,000, 51 the generation of a DNA chip covering the whole genome of a vertebrate, especially of humans, is not out of reach. A major problem consists in the complexity of the human genes, with more alternative splicing generating a larger number of protein products. The identi®cation of all these splice variants on the one hand, and the corresponding selection of array-suitable DNA fragments or oligonucleotides on the other hand, complicate the generation of an`allinclusive' microarray suitable for the analysis of the complete human transcriptome. Addressing this problem, Shoemaker et al. used microarray technology for an experimental annotation of the human genome. 48 They devised an experimental approach to validate and re®ne computational gene predictions and de®ne full-length transcripts on the basis of co-regulated expression of their exons. Among other applications, their method allows the detection of mRNA splice variants and the identi®cation of the tissue-and disease-speci®c conditions under which genes are expressed.
Often, not the complete coverage of a genome, but rather the investigation of de®ned biological questions or subject and tissue-speci®c arrays. 31 Besides the general selection criteria, the topic chosen either dictates the choice of relevant genes or, at least, offers some guidelines to gene selection.
A general preselection can occur by expected visibility. Although the detection of mRNA molecules in concentrations of 0.5±1.5 copies/cell is possible, 9 low-copy genes or genes that are only expressed at inappropriate developmental stages of an organism may not be suited for a targeted array. Information on the relative expression rate of an mRNA species can be estimated from the frequency of SAGE tags or EST clones in the respective libraries. An important selection criterion is the participation of the genes of interest in a particular biological process, eg a signal transduction or metabolic pathway. A classi®cation of genes by three organising principles (molecular function, biological process, cellular component), provided by the Gene Ontology Consortium 52 is a useful resource for gene categorisation. A universally applicable classi®cation system is also a prerequisite for supervised clustering 53 of the array results. A very useful strategy to select genes for the study of systems with little prior information is the application of unbiased pre-screens. 54, 55 
CONCLUSIONS
The application of DNA microarrays to expression pro®ling opens new avenues for molecular biologists, pharmacologists and physicians to a deeper understanding of biological processes. Practical applications range from the discovery of potential new drug targets to early toxicological risk assessment and support for medical decision making. To exploit the potential of this emerging technology fully, it is essential that manufacturers and users of microarrays are aware of the relevance of the probe design strategy for the interpretation of their results. The method of choice depends on the application and the problem to be solved. In general, high-throughput procedures do not require an intensive scrutiny of the spotted DNA fragments before the hybridisation. On the downside, substantial bioinformatical analysis work has to be performed for each spot showing an interesting expression behaviour. Targeted arrays, on the other hand, do not aim at the identi®cation of new genes, but allow the monitoring of complex expression patterns and their alteration, eg as a result of pathological conditions. This objective, in particular with regard to medical applications, requires a careful annotation and quality control of the DNA fragments to allow a reliable and rapid interpretation of the results. In most cases, a compromise between optimal fragment design and practicability and affordability has to be made. In the last instance, it is the decision of the user as to which strategy is the most suitable one for the application.
A number of recent works have shown that, in several array applications for clinical diagnosis, the decision-making process works just as well (or even better) when only a few array features are used for the analysis. 56±58 Since for most disease states the nature of the probes optimal for diagnosis is not known a priori, a twostage approach, combining the best of both worlds, will probably become the method of choice. First, an unbiased prescreen with high-density arrays or SAGErelated methods aims to identify those genes optimally suited for diagnosis. In the second step, low-density arrays with a small number of carefully selected features can be used for the actual diagnostic application.
A list of useful WWW-links pertaining to the problem of array probe selection is given in Table 1 
